Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Neonc Technologies, Inc.
Inhibrx Biosciences, Inc
Toray Industries, Inc
M.D. Anderson Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
GI Innovation, Inc.
Eli Lilly and Company
GlaxoSmithKline
Nektar Therapeutics
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey